Hyperprolactinemia following chronic alcohol administration

Frontiers of Hormone Research

Volumn 38, Issue , 2010, Pages 32-41

  Sarkar, Dipak K ^a  

^a The State University of New Jersey   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BASIC FIBROBLAST GROWTH FACTOR; CYCLIC AMP; DOPAMINE 2 RECEPTOR; ESTRADIOL; GROWTH FACTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROLACTIN; TRANSFORMING GROWTH FACTOR BETA;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; CELL COMMUNICATION; CELL PROLIFERATION; DISEASE ASSOCIATION; HUMAN; HYPERPROLACTINEMIA; NONHUMAN; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; REVIEW; RISK FACTOR;

ALCOHOLISM; ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GTP-BINDING PROTEINS; HUMANS; HYPERPROLACTINEMIA; LACTOTROPHS; RECEPTORS, DOPAMINE D2; TRANSFORMING GROWTH FACTOR BETA3;

EID: 84926116668     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000318492     Document Type: Review

References (55)

1. Kelley WN (ed): Text Book of Internal Medicine. New York, Lippincott 1996, pp 1-1983.
2. MacLeod RM, Scapagnini U, Thorner MO: Pituitary Microadenomas. New York Academic Press 1980, pp 683-855.
3. Tonner D, Schlechte J: Contemporary therapy of prolactin-secreting adenomas. Am J Med Sci 1993; 306:395-397.
4. Van Thiel DH: Feminization of chronic alcoholic men: a formulation. Yale J Biol Med 1979;52:219-225.
5. Seki M, Yoshida K, Okamura Y: A study on hyper-prolactinemia in female patients with alcoholics. Jpn J Alcohol Drug Depend 1991;26:49-59.
6. Teoh SK, Lex BW, Mendelson JH, Mello NK, Cochin J: Hyperprolactinemia and macrocytosis in women with alcohol and polysubstance dependence. J Stud Alcohol 1992;53:176-182.
7. Välimäki M, Pelkonen R, Härkönen M, Tuomala P, Koistinen P, Roine R, Ylikahri R: Pituitary-gonadal hormones and adrenal androgens in non-cirrhotic female alcoholics after cessation of alcohol intake. Eur J Clin Invest 1990;20:177-181.
8. Mendelson JH, Mello NK: Chronic alcohol effects on anterior pituitary and ovarian hormones in healthy women. J Pharmacol Exp Ther 1988;245: 407-412.
9. Gavaler JS: 1994 Aging and alcohol: the hormonal status of postmenopausal women; in Sarkar DK, Barnes C (eds): Reproductive Neuroendocrinology of Aging and Drug Abuse. Boca Raton, CRC Press, 1994, pp 365-378.
10. Ida Y, Isujimararu S, Nakamaura K, Shirrao I, Mukasa H, Egami H, Nakazawa Y: Effects of acute and repeated alcohol ingestion on hypothalamic-pituitary- gonadal and hypothalamic-pituitary-adre-nal functioning in normal males. Drug Alcohol Depend 1992;31:57-64.
11. Marchesi C, De Risio C, Campanini G, Majgini C, Piazza P, Grassi M, Chiodera P, Criro V: TRH test in alcoholics: relationship of the endocrine results with neuroendocrinological and neuropsychological findings. Alcohol Alcohol 1992;27:531-537.
12. Soyka M, Gorig E, Naber D: Serum prolactin increase induced by ethanol-a dose dependent effect not related to stress. Psychoneuroendocrinology 1991;16:441-446.
13. Kornet M, Goosen C, Thyssen JH, Van Ree JM: Endocrine profile during acquisition of free-choice alcohol drinking in rhesus monkeys: treatment with desglycinamide-(Arg 8)-vasopressin. Alcohol Alcohol 1991;27:403-410.
14. Mello NK, Mendelson JH, Bree MP, Skupny A: Alcohol effects on naloxone-stimulated luteinizing hormone, follicle-stimulating hormone and prolac-tin plasma levels in female Rhesus monkeys. J Pharmacol Exp Ther 1988;245:895-904.
15. Mello NK, Bree MP, Mendelson JH, Ellingboe J, King N W, Sehgal P: Alcohol self-administration disrupts reproductive function in female macaque monkeys. Science 1983;221:677-679.
16. De A, Boyadjieva N, Pastorcic M, Sarkar DK: Potentiation of estrogen's mitogenic effect on the pituitary gland by alcohol consumption. Int J Oncol 1995;7:643-648.
17. Ben-Jonathan N, Hnasko R: Dopamine as a prolac-tin (PRL) inhibitor. Endocr Rev 2001;22:724-763.
18. Missale C, Nash SR, Robinson SW, Jaber M, Caron MG: Dopamine receptors: from structure to function. Physiol Rev 1998;78:189-225.
19. Robbins T W, Everitt BJ: Drug addiction: bad habits add up. Nature 1999;398:567-570.
20. Tupala E, Hall H, Bergstrom K, Sarkioja T, Rasanen P, Mantere T, Callaway J, Hiltunen J, Tiihonen J: Dopamine D-2/D-3-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol Psychiatry 2001;6:261-267.
21. Blum K, Noble E P, Sheridan PJ, Finley O, Montgomery A, Ritchie T, Ozkaragoz T, Fitch RJ, Sadlack F, Sheffield D: Association of the A1 allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991;8:409-416.
22. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH: The dop-amine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 1989;8:4025-4034.
23. Albert PR: G protein preferences for dopamine D2 inhibition of prolactin secretion and DNA synthesis in GH(4) pituitary cells. Mol Endocrinol 2002;16: 1903-1911.
24. Senogles SE: The D2 dopamine receptor isoforms signal through distinct Gi alpha proteins to inhibit adenylyl cyclase: a study with site-directed mutant Gi alpha proteins. J Biol Chem 1994;269:23120-23127.
25. Senogles SE: The D2s dopamine receptor stimulates phospholipase D activity: a novel signaling pathway for dopamine. Mol Pharmacol 2000;58:455-462.
26. Oomizu S, Boyadjieva N, Sarkar DK: Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor mRNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland. Alcohol: Clin Exp Res 2003;27: 975-980.
27. Marchesi C, Ampollini P, Chiodera P, Volpi R, Coiro V: Alteration in dopaminergic function in abstinent alcoholics. Neuropsychobiology 1997;36:1-4.
28. Markianos M, Moussas G, Lykouras L, Hatzimanolis J: Dopamine receptor responsivity in alcoholic patients before and after detoxification. Drug Alcohol Depend 2000;57:261-265.
29. Dal Toso R, Sommer B, Ewert M, Herb A, Pritchett DB, Bach A, Shivers BD, Seeburg PH: The dop-amine D2 receptor: two molecular forms generated by alternative splicing. EMBO J 1989;8:4025-4034.
30. Guivarc'h D, Vincent JD, Vernier P: Alternative splicing of the D2 dopamine receptor messenger ribonucleic acid is modulated by activated sex steroid receptors in the MMQ prolactin cell line. Endocrinology 1998;139:4213-4221.
31. Livingstone JD, Lerant A, Freeman ME: Ovarian steroids modulate responsiveness to dopamine and expression of G-proteins in lactotropes. Neuroendo-crinology 1998;68:172-179.
32. Fan S, Meng Q, Gao B, Grossman J, Yadegari M, Goldberg ID, Rosen EM: Alcohol stimulates estrogen receptor signaling in human breast cancer cell lines. Cancer Res 2000;60L:5635-5639.
33. Gilman AG: G proteins: transducers of receptor-generated signals. Ann Rev Biochem 1987;56:615-649.
34. Simon MI, Strathmann M P, Gautam N: Diversity of G proteins in signal transduction. Science 1991; 252:802-808.
35. Wilkie TM, Gilbert DJ, Olsen AS, Chen XN, Amatruda TT, Korenberg JR, Trask BJ, de Jong P, Reed RR, Simon MI, Jenkins NA, Copeland NG: Evolution of the mammalian G protein alpha sub-unit multigene family. Nat Genet 1992;2:85-91.
36. Vallar L, Meldolesi J: Mechanisms of signal trans-duction at the dopamine D2 receptor. Trends Pharmacol Sci 1989;10:74-77.
37. Dhanasekaran N, Dermott JM: Signaling by the G12 class of G proteins. Cell Signal 1996;8:235-245.
38. Ballare E, Mantovani S, Bassetti M, Lania A, Spada A: Immunodetection of G proteins in human pituitary adenomas: evidence for a low expression of proteins of the Gi subfamily. Euro. J Endocrinology 1997;137:482-489.
39. Chaturvedi K, Sarkar DK: Alteration in G proteins and prolactin levels in pituitary after ethanol and estrogen treatment. Alcohol Clin Exp Res 2008;32: 806-813.
40. Ghahremani MH, Cheng P, Lembo PM, Albert PR: Distinct roles for Gαi2, Gαi3, and Gβγγin modulation of forskolin-or Gs-mediated cAMP accumulation and calcium mobilization by dopamine D2S receptors. J Biol Chem 1999;274:9238-9245.
41. Tonner D, Schlechte J: Contemporary therapy of prolactin-secreting adenomas. Am J Med Sci 1993; 306:395-397.
42. Asa SL, Kelly MA, Grandy DK, Low ML: Pituitary lactotroph adenomas develop after prolonged lac-totroph hyperplasia in dopamine D2 receptor-deficient mice. Endocrinology 1999;140:5348-5355.
43. Sarkar DK, Gottschall PE, Meites J: Damage to hypothalamic dopaminergic neurons is associated with development of prolactin-secreting tumors. Science 1982;218:684-686.
44. Sarkar DK, Chaturvedi K, Oomizu, S, Boyadjieva N, Chen CP: Dopamine and TGF-β1 interact to inhibit the growth of pituitary lactotropes. Endocrinology 2005;146:4179-4188.
45. Hentges S, Sarkar DK: Transforming growth factor β regulation of estradiol-induced prolactinomas. Front Neuroendocrinol 2001;22:340-363.
46. Sarkar DK, Boyadjieva NI: Ethanol alters production and secretion of estrogen-regulated growth factors that control prolactin-secreting tumors in the pituitary. Alcohol Clin Exp Res 2007;31:2101-2105.
47. Geiser AG, Kim SJ, Roberts AB, Sporn MB: Characterization of the mouse transforming growth factor-beta 1 promoter and activation by the Ha-ras oncogene. Mol Cell Biol. 1991;11:84-92.
48. Pastorcic M, Sarkar DK: Down regulation of TGF-ß1 gene expression in anterior pituitary cells treated with forskolin. Cytokine 1997;9:106-111.
49. De A, Boyadjieva N, Oomizu S, Sarkar DK: Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats. Alcoholism: Clinical and Experimental Research 2002; 26:1420-1429.
50. Vila-Porcile E, Olivier L: The problem of folliculo-stellate cells in the pituitary gland; in Motta PM (ed): Ultrastructure of Endocrine Cells and Tissue. Boston, Martinus Nijhoff, 1984, pp 64-71.
51. Allaerts W, Denef C: Regulatory activity and topo-logical distribution of folliculo-stellate cells in rat anterior pituitary cell aggregates. Neuroendocrino-logy 1989;49:409-418.
52. Ferrara N, Schweigerer L, Neufeld G, Mitchell R, Gospodarowicz D: Pituitary follicular cells produce basic fibroblast growth factor. Proc Natl Acad Sci USA 1987;84:5773-5777.
53. Takahashi H, Nakagawa S: Effects of estrogen and fibroblast growth factor receptor induction in MtT/Se cells. Endocrine Res 1997;23:95-104.
54. Chaturvedi K, Sarkar DK: Role of PKC-Ras-MAPK p44/42 in ethanol and TGF-β3-induced bFGF release from folliculostellate cells. J Pharm Exp Ther 2005;314:1346-1352.
55. Chaturvedi K, Sarkar DK: Involvement of PKC dependent p44/42 MAP kinase signaling pathway for cross-talk between estradiol and TGF-β3 in increasing bFGF in folliculostellate cells. Endocrinology 2004;145:706-715.